Noticias of THE BINDING SITE
UK's Binding Site to Be Acquired by Thermo Fisher for USD 2.6 Billion
01 Nov 2022
Thermo Fisher Scientific Inc. (Waltham, MA; USA) has entered into a definitive agreement to acquire The Binding Site Group (Birmingham, UK) in an all-cash transaction valued at USD 2.6 billion.
Más info
Collaboration Improves Diagnosis and Monitoring of Multiple Myeloma
10 Mar 2017
The Binding Site Group Ltd. has entered into a collaboration agreement with Mayo Clinic to develop a clinical laboratory test for the identification and accurate measurement of monoclonal proteins present in B-cell diseases. Both the organizations have been involved in collaborative activities for more than two decades with the aim of improving the testing, diagnosis and monitoring of patients with multiple myeloma and related conditions. The output of the latest collaboration will build on combining The Binding Site’s antibody- and assay-development expertise with Mayo Clinic’s clinical excellence and its recently patented approach to improving multiple myeloma patient monitoring.
Más info